ITMCTR2100005344尚未招募4 期
Clinical Trial of Suxiao Jiuxin Pill to Protect Endothelial Function in Patients With Acute Coronary Syndrome
The second affiliated hospital of guangzhou university of traditional Chinese medicine Hospital guangzhou0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •(1) Both acute coronary syndrome and qi stagnation and blood stasis syndrome met the diagnostic criteria;
- •(2) Aged between 30 and 75;
- •(3) Patients or their family members agreed to participate in the study and signed informed consent.
- •Introduction period: Before the trial, patients should stop taking other Chinese patent medicines, TCM decoction and TCM injection for treating cardiovascular and cerebrovascular diseases or promoting blood circulation and removing blood stasis.
排除标准
- •(1) Permanent serious arrhythmia: III degree ATrioventricular block, pathological sinus syndrome;
- •(2) cardiac arrest, cardiopulmonary resuscitation (CPR);
- •(3) Severe heart failure: New York Heart function Grade III-IV;
- •(4) acute cerebrovascular diseases (ischemic stroke, hemorrhagic stroke);
- •(5) severe diseases of the blood system (hemophilia, severe anemia, thrombocytopenic purpura, primary thrombocytopenia);
- •(6) severe renal insufficiency (serum creatinine level =265umol/L);
- •(7) severe liver disease (cirrhosis or liver cancer), liver function damage (serum glutamic-pyruvic transaminase/glutamic-oxalacetic transaminase > 3 times the normal upper limit);
- •(8) patients who may affect drug absorption after gastrointestinal surgery;
- •(9) Malignant tumors or life expectancy =2 years;
- •(10) persons with mental disorders or low intelligence;
- •(11) patients requiring coronary artery bypass graft (heart bypass graft);
- •(12) allergic to the known ingredients of the test drug;
- •(13) severe respiratory diseases such as severe chronic obstructive pulmonary disease, severe pulmonary hypertension and pulmonary embolism;
- •(14) women who are breast-feeding or pregnant, or women of childbearing age who plan to have a pregnancy within 6 months after screening, or who have a positive urine pregnancy test; Or male patients with fertility or sperm donation plans;
- •(15) Suspected or confirmed history of alcohol or drug abuse;
- •(16) Screening of patients who had participated in clinical trials of other drugs within 3 months prior to the examination;
- •(17) other patients considered unsuitable for the study by the investigator;
- •(18) long-term oral anticoagulants.
研究者
相似试验
尚未招募
2 期
EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin PillAcute Mountain SicknessNCT06531161Peking University First Hospital168
尚未招募
4 期
Clinical trial of Zhen Shu Tiu Zhi Capsule in treating diabetic damp heat syndrome and study on biological basis of damp heat syndrome of glycolipid metabolic diseasesDiabetesITMCTR2200005519Dongzhimen Hospital, Beijing University of Chinese Medicine
已完成
2 期
Clinical study for Xiangbin prescription for promoting recovery of gastrointestinal function after gynecological surgeryITMCTR1900002637The Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine
尚未招募
1 期
Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19)ovel Coronavirus Pneumonia (COVID-19)ITMCTR2000003243Beijing University of Chinese Medicine Third Affiliated Hospital
尚未招募
1 期
Clinical Study of ShuangPiZhuoYu prescription in the Treatment of RosaceaITMCTR2022000093Xiyuan Hospital, Chinese Academy of traditional Chinese Medicine